Golden West Diagnostics, LLC. specializes in processing human native matrixes for use in standards & controls for immunoassay & mass spectrometry. The company, founded in 2015, is a subsidiary of Golden West Biologicals, Inc., which has been in business since 1989. GWD is ISO 13485:2016 certified and focuses on manufacturing components for further manufacturing and\/or research. Roughly 60% of all business for GWD is considered Custom OEM, allowing the company to work with a wide range of products and processes, providing cost-effective and specific solutions. As part of the Golden West conglomerate, GWD, along with its parent and sibling companies, offers an extensive distribution network and manufacturing capabilities, providing unrivaled quality and value to its customers in the in-vitro diagnostic industry. The company's product line includes human matrices used in the preparation of controls and standards, human and animal protein fractions, and ultra-low analyte matrices for vitamins, steroids, hormones, and toxicology. With a focus on biotechnology and manufacturing, GWD continues to develop innovative solutions to meet industry needs. While specific present financial details are unavailable, the company's strategic positioning within the biotechnology and diagnostics industry presents interesting investment opportunities for investors looking to participate in the growing demand for advanced diagnostic solutions.
There is no investment information
No recent news or press coverage available for Golden West Diagnostics, LLC.